To help unravel the mysteries of COVID-19, scientists are sequencing the DNA of young, healthy adults and children who develop severe illness despite having no underlying medical problems. The researchers are looking for ...
May 21, 2020
0
5
Long-lasting immune cells that specifically recognize the SARS-CoV-2 virus were found in the noses of people who were infected following vaccination. These virus-specific T cells, which were not present in those who had only ...
Sep 9, 2022
0
57
Nearly two years since becoming a global pandemic that has killed millions of people, the mystery of which proteins in the SARS-CoV-2 virus are responsible for severe vascular damage that could even lead to heart attack or ...
Nov 3, 2021
0
594
New research presented at the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27–30 April) shows that in a VACCELERATE Consortium survey study in which infectious diseases experts were asked to rank pathogens ...
Apr 20, 2024
1
19
Since the beginning of the COVID-19 pandemic caused by the SARS-CoV-2 virus, researchers have been trying to determine why this virus creates such negative long-term effects compared with most coronaviruses.
Aug 9, 2023
0
136
Can COVID-19 infection increase the risk of developing Parkinson's disease?
Oct 22, 2020
0
8
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut ...
Dec 8, 2023
1
85
Seeking to understand why COVID-19 is able to suppress the body's immune response, new research from the USC Leonard Davis School of Gerontology suggests that mitochondria are one of the first lines of defense against COVID-19 ...
Jan 11, 2021
0
312
A multidisciplinary team at The University of Texas Medical Branch at Galveston working to combat the COVID-19 virus has a system that will unlock researchers' ability to more quickly develop and evaluate developing vaccines, ...
Apr 6, 2020
0
241
A new study led by scientists at La Jolla Institute for Immunology (LJI) suggests that T cells try to fight SARS-CoV-2 by targeting a broad range of sites on the virus—beyond the key sites on the virus's spike protein. ...
Jan 27, 2021
1
331
